Citigroup »

G1 Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $262k 86k 3.05
2023-09-30 $925 643 1.44
2023-03-31 $4.4k 1.7k 2.68
2022-12-31 $133k 24k 5.43
2022-09-30 $1.6M 127k 12.49
2021-12-31 $2.7M 267k 10.21
2021-03-31 $4.2M 177k 24.06
2020-12-31 $147k 8.2k 18.01
2020-09-30 $37k 3.2k 11.41
2020-06-30 $577k 24k 24.25
2020-03-31 $310k 28k 11.03
2019-12-31 $327k 12k 26.60
2019-09-30 $621k 27k 22.82
2019-06-30 $459k 15k 30.65
2019-03-31 $236k 14k 16.61
2018-12-31 $2.2M 113k 19.16
2018-09-30 $1.8M 35k 52.30
2018-06-30 $969k 22k 43.46
2018-03-31 $74k 2.0k 37.08
2017-12-31 $36k 1.9k 19.56